Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: In vitro synergistic cytotoxicity and DNA-induced strand-breaks

European Journal of Cancer Part A

Volumn 32, Issue 7, 1996, Pages 1219-1226

  Andreuccetti, M ^a   Allegrini, G ^b   Antonuzzo, A ^b   Malvaldi, G ^a   Conte, P F ^b   Danesi, R ^c   Del Tacca, M ^a   Falcone, A ^b  

^a UNIVERSITY OF PISA   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c Scuola Superiore di Studi   (Italy)

Author keywords

5 fluorouracil; azidothymidine; colorectal cancer cell lines; DNA strand breaks; synergistic cytotoxicity

Indexed keywords

ELONGATION FACTOR; FLUOROURACIL; ZIDOVUDINE;

ARTICLE; CANCER CELL; COLORECTAL CANCER; CYTOTOXICITY; DNA DAMAGE; DNA DENATURATION; DNA STRAND BREAKAGE; DNA SYNTHESIS; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 0343262547     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00018-4     Document Type: Article

References (38)

1. 1. Furman PA, Fyfe JA, St. Clair MH, et al. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 1986, 83, 8333-8337.
2. 2. Horowitz JP, Chua J, Noel MJ. Nucleosides. V. The monomesylates of 1-(2′-deoxy-beta-D-lyxofuranosyl)thymidine. J Org Chem 1964, 29, 2076-2078.
3. 3. Wilde MI, Langtry HD. Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 1993, 46, 515-578.
4. 4. Mitsuya H, Weinhold KJ, Furman PA, et al. 3′-Azido-3′-deoxythymidine: an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985, 82, 7096-7100.
5. 5. Fischl MA, Richmann DD, Grieco MH, et al. The efficacy of azidothymidine in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1987, 317, 185-191.
6. 6. Brunetti I, Falcone A, Calabresi P, et al. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies. Cancer Res 1990, 50, 4026-4031.
7. 7. Tosi P, Calabresi P, Goulette FA, et al. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo. Cancer Res 1992, 52, 4069-4073.
8. 8. Darnowski JW, Goulette FA. 3′-Azido-3′-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8. Biochem Pharmacol 1994, 48, 1797-1805.
9. 9. Denton JE, Lui MS, Aoki T, et al. Enzymology of pyrimidine and carbohydrate metabolism in human colon carcinomas. Cancer Res 1982, 42, 1176-1183.
10. 10. Weber G, Lui MS, Takeda E, et al. Enzymology of human colon tumors. Life Sci 1980, 27, 793-799.
11. 11. Sakamoto S, Sagara T, Iwama T, et al. Increased activity of thymidine kinase isozymes in human colon polyp and carcinoma. Carcinogenesis 1985, 6, 917-919.
12. 12. Herzfeld A, Legg MA, Greengard O. Human colon tumors. Enzymic and histological characteristics. Cancer 1978, 42, 1280-1283.
13. 13. Wohlhueter RM, Marz R, Plagemann PGW. Thymidine transport in cultured mammalian cells. Kinetic analysis, temperature dependence and specificity of the transport system. Biochim Biophys Acta 1979, 553, 262-283.
14. 14. Paterson ARP, Kolassa N, Cass CE. Transport of nucleoside drugs in animal cells. Pharmacol Ther 1981, 12, 516-536.
15. 15. Dagnino L, Bennett LL, Paterson ARP. Concentrative transport of nucleosides in L1210 mouse leukemia cells. Proc Am Assoc Cancer Res 1987, 28, 15.
16. 16. Belt JA, Vijayalakshmi D. Sodium-dependent nucleoside transport in mouse intestinal epithelial cells: two transporters with differing substrate specificities. Proc Am Assoc Cancer Res 1988, 29, 13.
17. 17. Domin BA, Mahony WB, Zimmerman TP. 2′-3′-Dideoxythymidine permeation of the human erythrocyte membrane by non-facilitated diffusion. Biochem Biophys Res Commun 1988, 154, 825-831.
18. 18. Fogh J, Trempe G. New human tumor cell lines. In Fogh J, ed. Human Tumor Cells in Vitro. New York, Plenum Publishing, 1975, 115-159.
19. 19. Leibovitz A, Stinson JC, McCombs WB, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res 1976, 36, 4562-4569.
20. 20. Quinn LA, Moore GE, Morgan RT, Woods LK. Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res 1979, 39, 4914-4924.
21. 21. Scudiero DA, Shoemaker RH, Paull KD, et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988, 48, 4827-4833.
22. 22. Birnboim HC, Jevcak JJ. Fluorometric method for rapid detection of DNA strand breaks in human blood cells produced by low dose of radiation. Cancer Res 1981, 41, 1889-1892.
23. 23. Steel GG, Peckham MJ. Exploitable mechanisms in combined radiotherapy-chemotheapy: the concept of additivity. Int J Radiat Oncol Biol Phys 1979, 5, 85-91.
24. 24. Kano Y, Ohnuma T, Okano T, et al. Effects of vincristine in combination with methotrexate and other anti-tumor agents in human lymphoblastic leukemia cells in culture. Cancer Res 1988, 48, 351-356.
25. 25. Tsai CM, Hsiao SH, Frey CM, et al. Combination cytotoxicity effects of cis-diamminodichloroplatinum and 5-fluorouracil with and without leucovorin against human non-small cell cancer cell lines. Cancer Res 1993, 53, 1079-1084.
26. 26. Falcone A, Danesi R, Zaccaro L, et al. Synergistic antiproliferative activity of suramin and α2A-interferon against human colorectal adenocarcinoma cell lines: in vitro studies. Eur J Cancer 1994, 30A, 516-520.
27. 27. Sayers TJ, Wiltrout TA, McCormick K, Husted C, Wiltrout RH. Antitumor effects of α-interferon and γ-interferon on a murine renal cancer (Renca) in vitro and in vivo. Cancer Res 1990, 50, 5414-5420.
28. 28. Ahlgren JD. Colorectal cancer: chemotherapy. In Ahlgren JD, Macdonald JS, eds. Gastrointestinal Oncology. Philadelphia, J.B. Lippincott, 1992, 339-357.
29. 29. Advanced Colorectal Cancer Meta-Analysis Project. Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 1994, 12, 960-969.
30. 30. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992, 10, 896-903.
31. 31. Sotos GA, Grogan L, Allegra J. Preclinical and clinical aspects of biomodulation of 5-fluorouracil. Cancer Treat Rev 1994, 20, 11-19.
32. 32. Tosi P, Visani G, Ottaviani E, et al. Hydroxyurea enhances 3′-azido-3′-deoxythymidine (AZT) cytotoxicity in human chronic myeloid leukemia models. Eur J Haematol 1994, 52, 291-295.
33. 33. Presacco J, Erlichman C. Combination studies with 3′-azido-3′-deoxythymidine plus ICI D1694: cytotoxic and biochemical effects. Biochem Pharmacol 1993, 46, 1989-1992.
34. 34. Szekeres T, Findenig G, Fritzer M, Mader R, Schon HJ. Synergistic cytotoxic effects of 5-fluorouracil with AZT in human colon carcinoma cells. Proc Am Assoc Cancer Res 1995, 36, 297.
35. 35. Posner MR, Darnowski JW, Weitberg AB, et al. High-dose intravenous zidovudine with 5-fluorouracil and leucovorin. A phase I trial. Cancer 1992, 70, 2929-2934.
36. 36. Browne MJ, Beitz J, Clark FJ, et al. A phase I study of zidovudine combined with methotrexate in patients with advanced cancer. Proc Am Soc Clin Oncol 1993, 12, 163.
37. 37. Falcone A, Dargenio F, Brunetti I, et al. Intravenous azidothymidine in combination with 5-fluorouracil and 1-folinic acid: a phase I-II study in metastatic colorectal carcinoma. Proc Am Soc Clin Oncol 1994, 13, 198.
38. 38. Tosi P, Gherlinzoni F, Visani G, et al. Zidovudine as an antineo-plastic agent in the treatment of HIV related high-grade non-Hodgkin lymphoma. Blood 1994, 84 (Suppl. 1), 518a.